SCHEMBL30482913

SCHEMBL30482913

Fc1ccccc1-n1cc(C(F)(F)F)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.47
NOTUM Q6P988 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MTOR P42345 1/20 0.41
DYRK1B Q9Y463 5/20 0.40
EPHX2 P34913 1/20 0.40
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
GAA P10253 1/20 0.39
ATM Q13315 1/20 0.39
CDK1 P06493 1/20 0.38
CDK4 P11802 1/20 0.38
CCNB1 P14635 1/20 0.38
CCND1 P24385 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29303971 0.86 GRM4 (0.45) GRM4NOTUMMTORDYRK1BDRD2
SCHEMBL20282340 0.83 GRM4 (0.43) GRM4NOTUMCYP2C9MTORDYRK1B
SCHEMBL2047296 0.81 EPHX2 (0.45) CYP1A2CYP2C19EPHX2GAACYP46A1
SCHEMBL20282263 0.79 NOTUM (0.40) GRM4NOTUMMTORDYRK1BDRD2
SCHEMBL24352877 0.77 CYP3A4 (0.43) CYP3A4EPHX2CYP46A1ALDH1A1
SCHEMBL2045755 0.77 MTOR (0.44) CYP1A2CYP3A4CYP2C9CYP2C19MTOR
SCHEMBL31149031 0.77 MTOR (0.44) CYP1A2CYP3A4CYP2C9CYP2C19MTOR
SCHEMBL30332214 0.77 PDE9A (0.41) GRM4NOTUMEPHX2CYP46A1ALDH1A1
SCHEMBL5546869 0.76 GRM4 (0.48) GRM4NOTUMCYP1A2CYP2C9MTOR
SCHEMBL3626706 0.76 MAPT (0.50) GRM4NOTUMMTORDYRK1BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023130043-A1 MONOACYLGLYCEROL LIPASE INHIBITORS AND USE THEREOF FOR THE TREATMENT OF ANXIETY PSY THERAPEUTICS, INC. (US) 2023-07-06 WO disclosed